CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	9 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Cash flows from operating activities:
Net income	$ 282,958	$ 856,456
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	97,295	95,206
Amortization of intangible assets	105,531	117,288
Amortization of debt issuance costs	8,569	8,457
Deferred income tax benefit	(9,052)	(18,830)
(Gain) loss on disposition of property, plant and equipment	(374)	833
Stock-based compensation expense	26,607	22,736
Changes in assets and liabilities:
Accounts receivable	143,591	(256,180)
Inventories, net	(87,841)	(338,852)
Prepaid income taxes, expenses and other	2,119	(4,578)
Accounts payable	(63,642)	78,897
Accrued liabilities	(35,388)	92,693
Long-term liabilities and other	3,747	(16,577)
Net cash provided by operating activities	474,120	637,549
Cash flows from investing activities:
Purchases of property, plant and equipment	(150,466)	(170,702)
Proceeds from dispositions of property, plant and equipment	4,179	823
Business acquisitions, net of cash acquired	(6,184)	(781,967)
Other	(19,091)	(20,000)
Net cash used in investing activities	(171,562)	(971,846)
Cash flows from financing activities:
Borrowings on revolving asset-based credit facilities	0	660,088
Payments on revolving asset-based credit facilities	(50,000)	(559,035)
Proceeds from issuance of senior unsecured notes	0	500,000
Payments on term-loan credit facilities	(102,355)	(124,565)
Payments on other debt	(8,155)	(7,842)
Payments of debt issuance costs	0	(8,445)
Cash dividends paid	(71,978)	(71,496)
Payments on finance lease obligations	(905)	(801)
Purchases of treasury shares	(42,007)	(98,321)
Payments related to vesting of stock-based awards	(6,765)	(18,011)
Short-term financial obligations and other, net	16,097	(21,120)
Net cash provided by (used in) financing activities	(266,068)	250,452
Effect of exchange rate changes on cash and cash equivalents and restricted cash	5,183	(32,882)
Net increase (decrease) in cash and cash equivalents and restricted cash	41,673	(116,727)
Cash and cash equivalents and restricted cash, beginning of period	311,553	448,706
Cash and cash equivalents and restricted cash, end of period	353,226	331,979
Cash and cash equivalents and restricted cash, total	353,226	331,979
Less: restricted cash	0	2,682
Cash and cash equivalents	353,226	329,297
Supplemental cash flow information:
Income taxes paid	118,602	270,063
Interest paid	75,877	59,454
Non-cash investing and financing transactions:
Capital expenditures in accounts payable	$ 4,874	$ 7,914